Biocon approves early redemption of Rs 1,070 crore debentures

Results View source PDF Explain this filing

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.4%Reaction day

₹346.80

prior close

₹347.60

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.8%+0.5% vs market

Pharmaceuticals peers, median of 151sector+0.2%+1.2% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Midcap 150 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.1

10m

+0.3

15m

+0.4

30m

+0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.4+0.8+0.5+0.2+1.2

Next day

+0.2+1.6-1.3+0.0+0.2

+0.6+2.0-1.3-0.3+1.0

+0.4+1.2-0.8-0.9+1.3

+1.5+2.1-0.6-0.4+1.9

+1.8+2.5-0.7-0.1+1.9

+1.2+1.8-0.6-1.2+2.3

15d

+4.1+4.0+0.1-0.7+4.8

+9.1+4.7+4.4+0.4+8.7

+18.4+4.3+14.1-4.1+22.5

+12.9+6.3+6.6-5.3+18.2

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Biocon's board approved early full redemption of 107,000 unlisted, secured, rated and redeemable non-convertible debentures issued through private placement on February 21, 2023. Each has a face value of Rs 1 lakh, totalling Rs 1,070 crore. The company said it paid the due amount to the debenture holders and trustee on October 1, 2025.

Likely market impact

The redemption retires Rs 1,070 crore of debt and reduces future interest obligations. No interest savings or profit impact was disclosed.